Clinical Trials Browser

OTHER × Osteosarcoma × surufatinib × Clear all

NCT05926492 2024-04-17

A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

Phase 2 Recruiting

Osteosarcoma

NCT05590572 2022-10-21

A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Phase 1/2 Not yet recruiting

Osteosarcoma